Jul. 19, 2022

Ten Moving Targets: 2022Q1

drughunter.com
Drug Hunter Team

Target-driven drug discovery evolves over time and is influenced by understanding of disease biology, technical innovation, and most of all, clinical data. Our new series reviews drug targets with significant recent clinical data or industry events that have influenced or changed recent perceptions of them. Here we look at 10 targeted agents with indications in oncology, immunology, and other diseases with:

  • interesting new clinical readouts

  • significant updated regulatory actions

  • start-up launches or other recent news

that make these targets worth taking a closer look at.

Loading...

twitterlinkedinemail

Other articles you may be interested in